145 related articles for article (PubMed ID: 20549340)
21. Growth-inhibitory activity of melatonin on murine foregastric carcinoma cells in vitro and the underlying molecular mechanism.
Xu L; Liu H; Zhang H; Wang RX; Song J; Zhou RX
Anat Rec (Hoboken); 2013 Jun; 296(6):914-20. PubMed ID: 23564716
[TBL] [Abstract][Full Text] [Related]
22. Human melatonin MT1 receptor induction by valproic acid and its effects in combination with melatonin on MCF-7 breast cancer cell proliferation.
Jawed S; Kim B; Ottenhof T; Brown GM; Werstiuk ES; Niles LP
Eur J Pharmacol; 2007 Mar; 560(1):17-22. PubMed ID: 17303109
[TBL] [Abstract][Full Text] [Related]
23. MT1 and MT2 melatonin receptors are expressed in nonoverlapping neuronal populations.
Klosen P; Lapmanee S; Schuster C; Guardiola B; Hicks D; Pevet P; Felder-Schmittbuhl MP
J Pineal Res; 2019 Aug; 67(1):e12575. PubMed ID: 30937953
[TBL] [Abstract][Full Text] [Related]
24. Antiestrogens modulate MT1 melatonin receptor expression in breast and ovarian cancer cell lines.
Treeck O; Haldar C; Ortmann O
Oncol Rep; 2006 Jan; 15(1):231-5. PubMed ID: 16328061
[TBL] [Abstract][Full Text] [Related]
25. Regulation of bone mass through pineal-derived melatonin-MT2 receptor pathway.
Sharan K; Lewis K; Furukawa T; Yadav VK
J Pineal Res; 2017 Sep; 63(2):. PubMed ID: 28512916
[TBL] [Abstract][Full Text] [Related]
26. Melatonin inhibits cholangiocyte hyperplasia in cholestatic rats by interaction with MT1 but not MT2 melatonin receptors.
Renzi A; Glaser S; Demorrow S; Mancinelli R; Meng F; Franchitto A; Venter J; White M; Francis H; Han Y; Alvaro D; Gaudio E; Carpino G; Ueno Y; Onori P; Alpini G
Am J Physiol Gastrointest Liver Physiol; 2011 Oct; 301(4):G634-43. PubMed ID: 21757639
[TBL] [Abstract][Full Text] [Related]
27. Study on pineal function and DMBA-induced breast cancer formation in rats during exposure to a 100-mG, 50 Hz magnetic field.
Mevissen M; Lerchl A; Löscher W
J Toxicol Environ Health; 1996 Jun; 48(2):169-85. PubMed ID: 8642624
[TBL] [Abstract][Full Text] [Related]
28. Cancer as the main aging factor for humans: the fundamental role of 5-methoxy-tryptamine in reversal of cancer-induced aging processes in metabolic and immune reactions by non-melatonin pineal hormones.
Lissoni P; Messina G; Rovelli F
Curr Aging Sci; 2012 Dec; 5(3):231-5. PubMed ID: 23451999
[TBL] [Abstract][Full Text] [Related]
29. Tumor prevention by 9-cis-retinoic acid in the N-nitroso-N-methylurea model of mammary carcinogenesis is potentiated by the pineal hormone melatonin.
Nowfar S; Teplitzky SR; Melancon K; Kiefer TL; Cheng Q; Dwived PD; Bischoff ED; Moro K; Anderson MB; Dai J; Lai L; Yuan L; Hill SM
Breast Cancer Res Treat; 2002 Mar; 72(1):33-43. PubMed ID: 12004806
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway.
Mao L; Yuan L; Slakey LM; Jones FE; Burow ME; Hill SM
Breast Cancer Res; 2010; 12(6):R107. PubMed ID: 21167057
[TBL] [Abstract][Full Text] [Related]
31. [MT1 melatonin receptors and their role in the oncostatic action of melatonin].
Danielczyk K; Dziegiel P
Postepy Hig Med Dosw (Online); 2009 Sep; 63():425-34. PubMed ID: 19837985
[TBL] [Abstract][Full Text] [Related]
32. A combination of resveratrol and melatonin exerts chemopreventive effects in N-methyl-N-nitrosourea-induced rat mammary carcinogenesis.
Kisková T; Ekmekcioglu C; Garajová M; Orendáš P; Bojková B; Bobrov N; Jäger W; Kassayová M; Thalhammer T
Eur J Cancer Prev; 2012 Mar; 21(2):163-70. PubMed ID: 22044852
[TBL] [Abstract][Full Text] [Related]
33. Clinical aspects of the melatonin action: impact of development, aging, and puberty, involvement of melatonin in psychiatric disease and importance of neuroimmunoendocrine interactions.
Waldhauser F; Ehrhart B; Förster E
Experientia; 1993 Aug; 49(8):671-81. PubMed ID: 8359273
[TBL] [Abstract][Full Text] [Related]
34. Signal transduction of the melatonin receptor MT1 is disrupted in breast cancer cells by electromagnetic fields.
Girgert R; Hanf V; Emons G; Gründker C
Bioelectromagnetics; 2010 Apr; 31(3):237-45. PubMed ID: 19882681
[TBL] [Abstract][Full Text] [Related]
35. Age dependent expression of melatonin membrane receptor (MT1, MT2) and its role in regulation of nitrosative stress in tropical rodent Funambulus pennanti.
Ahmad R; Gupta S; Haldar C
Free Radic Res; 2012 Feb; 46(2):194-203. PubMed ID: 22149391
[TBL] [Abstract][Full Text] [Related]
36. 5-Azacytidine upregulates melatonin MT
Hartung EE; Mukhtar SZ; Shah SM; Niles LP
Mol Biol Rep; 2020 Jun; 47(6):4867-4873. PubMed ID: 32410138
[TBL] [Abstract][Full Text] [Related]
37. Melatonin, selective and non-selective MT1/MT2 receptors agonists: differential effects on the 24-h vigilance states.
Ochoa-Sanchez R; Comai S; Spadoni G; Bedini A; Tarzia G; Gobbi G
Neurosci Lett; 2014 Feb; 561():156-61. PubMed ID: 24406151
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic inhibition of the tumor suppressor ARHI by light at night-induced circadian melatonin disruption mediates STAT3-driven paclitaxel resistance in breast cancer.
Xiang S; Dauchy RT; Hoffman AE; Pointer D; Frasch T; Blask DE; Hill SM
J Pineal Res; 2019 Sep; 67(2):e12586. PubMed ID: 31077613
[TBL] [Abstract][Full Text] [Related]
39. Two indoleamines are secreted from rat pineal gland at night and act on melatonin receptors but are not night hormones.
Lee BH; Bussi IL; de la Iglesia HO; Hague C; Koh DS; Hille B
J Pineal Res; 2020 Mar; 68(2):e12622. PubMed ID: 31715643
[TBL] [Abstract][Full Text] [Related]
40. Exposure of DMBA-treated female rats in a 50-Hz, 50 microTesla magnetic field: effects on mammary tumor growth, melatonin levels, and T lymphocyte activation.
Mevissen M; Lerchl A; Szamel M; Löscher W
Carcinogenesis; 1996 May; 17(5):903-10. PubMed ID: 8640936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
